Tf ligand-receptor-mediated exenatide-Zn²⁺ complex oral-delivery system for penetration enhancement of exenatide

References

• Chew BH, Vos RC, Metzendorf MI, et al. Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017;9:CD011469.
   PubMedGoogle Scholar
• Vasanth R, Ganesh A, Shanker R. Impact of stress on type 2 diabetes mellitus management. Psychiatr Danub. 2017;29(3):416–421.
   Web of Science ®Google Scholar
• American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(1):S67–S74.
   Google Scholar
• des Rieux A, Fievez V, Garinot M, et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116:1–27.
   PubMed Web of Science ®Google Scholar
• Fonte P, Araújo F, Silva C, et al. Polymer-based nanoparticles for oral insulin delivery: revisited approaches. Biotechnol Adv. 2015;33(63):1342–1354.
   Web of Science ®Google Scholar
• Hoffman AE. Ziv E. Pharmacokinetic considerations of new insulin formulations and routes of administration. Clin Pharmacokinet. 1997;33:285–301.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505–522.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lee H, Oh KS, et al. Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus. Biomaterials. 2013;34:8444–8449.
   PubMed Web of Science ®Google Scholar
• Wu L, Liu M, Shan W, et al. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. J Control Release. 2017;262:273–283.
   PubMed Web of Science ®Google Scholar
• Tobio M, Sánchez A, Vila A, et al. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids Surf B Biointerfaces. 2000;18:315–323.
   PubMed Web of Science ®Google Scholar
• Ramesan RM, Sharma CP. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev Med Devices. 2009;6:665–676.
   PubMed Web of Science ®Google Scholar
• Owens DE III, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93–102.
   PubMed Web of Science ®Google Scholar
• Li H, Sun H, Qian ZM. The role of the transferrin-transferrin-receptor system in drug delivery and targeting. Trends Pharmacol Sci. 2002;23:206–209.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wu J, Shan W, et al. Polymeric nanoparticles amenable to simultaneous installation of exterior targeting and interior therapeutic proteins. Angew Chem Int Ed. 2016;55:3309–3312.
   PubMed Web of Science ®Google Scholar
• Xia CQ, Wang J, Shen WC. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther. 2000;295:594–600.
   PubMed Web of Science ®Google Scholar
• Shah D, Shen WC. Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells. J Pharm Sci. 1996;85:1306–1311.
   PubMed Web of Science ®Google Scholar
• Li K, Yu L, Liu X, et al. A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel. Biomaterials. 2013;34:2834–2842.
   PubMed Web of Science ®Google Scholar
• Lisi GP, Hughes RP, Wilcox DE. Coordination contributions to protein stability in metal-substituted carbonic anhydrase. J Biol Inorg Chem. 2016;21:659–667.
   PubMed Web of Science ®Google Scholar
• Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70:399–421.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77.
   PubMed Web of Science ®Google Scholar
• Hong M, Zhu S, Jiang Y, et al. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release. 2009;133:96–102.
   PubMed Web of Science ®Google Scholar
• Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001;46:27–43.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xu J, Shan W, et al. The transport mechanism of integrin alphavbeta3 receptor targeting nanoparticles in Caco-2 cells. Int J Pharm. 2016;500:42–53.
   PubMedGoogle Scholar
• Zhang X, Sun M, Zheng A, et al. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Sci. 2012;45:632–638.
   PubMed Web of Science ®Google Scholar
• Kavimandan NJ, Losi E, Peppas NA. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates. Biomaterials. 2006;27:3846–3854.
   PubMed Web of Science ®Google Scholar
• Tros de Ilarduya C, Duzgunes N. Efficient gene transfer by transferrin lipoplexes in the presence of serum. Biochim Biophys Acta. 2000;1463:333–342.
   PubMed Web of Science ®Google Scholar
• Ochman AR, Lipinski CA, Handler JA, et al. The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes. J Pharmacol Exp Ther. 2012;342:23–32.
   PubMed Web of Science ®Google Scholar
• Lyons KC, Charman WN, Miller R, et al. Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion. Int J Pharm. 2000;199:17–28.
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Amidon GL, et al. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res. 1996;13:1838–1845.
   PubMed Web of Science ®Google Scholar
• Yoncheva K, Lizarraga E, Irache JM. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci. 2005;24:411–419.
   PubMed Web of Science ®Google Scholar
• Zhu ZB, Makhija SK, Lu B, et al. Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis. Virology. 2004;325:116–128.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Germain RS, Vuong PT, et al. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem. 2000;275:16618–16625.
   PubMed Web of Science ®Google Scholar
• Wiley DT, Webster P, Gale A, et al. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc Natl Acad Sci USA. 2013;110:8662–8667.
   PubMed Web of Science ®Google Scholar
• Fineman MS, Mace KF, Diamant M, et al. Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment. Diabetes Obes Metab. 2012;14:546–554.
   PubMed Web of Science ®Google Scholar